Skip to main content
. 2023 Jun 5:1–11. Online ahead of print. doi: 10.1007/s11046-023-00749-7

Fig. 3.

Fig. 3

ROC curve of the GM-LFA when testing serum samples A. Proven/Probable IA vs. No IA in all patients, B. Proven/Probable IA vs. No IA in patients without the use of mold-active antifungals on day 0. ROC: Receiver operator characteristic, GM: Galactomannan, LFA: Lateral flow assay, IA: Invasive aspergillosis